This application requests continued support for a postdoctoral training program for physicians and scientists seeking an intensive research experience in clinical immunology. The trainees will learn to apply advanced technology to specific problems in clinical immunology, with special emphasis on rheumatic, autoimmune, and lymphoproliferative diseases. The long-term objective of the program is to provide the trainees with the technical expertise and scientific judgment that will equip them for academic or research careers in clinical immunology. Each trainee will work together with one of the 10 staff preceptors. The program emphasizes the following areas: (1) the relationship between HLA antigens and rheumatoid arthritis; (2) molecular basis of autoantibody production; (3) mechanisms of joint and cartilage inflammation; (4) immunologic aging, autoimmunity, and lymphoproliferative disease; (5) biochemical basis of immunosuppressive therapy; (6) control of immune responses by gene therapeutics; and (7) pathogenesis of juvenile rheumatoid arthritis. The research of the staff preceptors is dedicated to the elucidation of the fundamental pathogenic mechanisms that trigger and sustain autoimmune and rheumatic diseases, and to the application of this knowledge toward the development of new therapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007567-08
Application #
2700189
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1991-07-01
Project End
2001-04-30
Budget Start
1998-05-01
Budget End
1999-04-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Wu, Christina C N; Hayashi, Tomoko; Takabayashi, Kenji et al. (2007) Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand. Proc Natl Acad Sci U S A 104:3990-5
Wu, Christina C N; Lee, Jongdae; Raz, Eyal et al. (2004) Necessity of oligonucleotide aggregation for toll-like receptor 9 activation. J Biol Chem 279:33071-8
Wu, Christina C N; Castro, Januario E; Motta, Marina et al. (2003) Selection of oligonucleotide aptamers with enhanced uptake and activation of human leukemia B cells. Hum Gene Ther 14:849-60
Ronaghy, Arash; Prakken, Berent J; Takabayashi, Kenji et al. (2002) Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J Immunol 168:51-6
Sen, Malini; Reifert, Jack; Lauterbach, Kevin et al. (2002) Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 46:2867-77
Chan, K; Lee, D J; Schubert, A et al. (2001) The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA. J Immunol 166:3061-6
Sen, M; Lauterbach, K; El-Gabalawy, H et al. (2000) Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A 97:2791-6
Kyburz, D; Corr, M; Brinson, D C et al. (1999) Human rheumatoid factor production is dependent on CD40 signaling and autoantigen. J Immunol 163:3116-22
Cary, S; Krishnan, M; Marion, T N et al. (1999) The murine clan V(H) III related 7183, J606 and S107 and DNA4 families commonly encode for binding to a bacterial B cell superantigen. Mol Immunol 36:769-76
Lee, D J; Abeyratne, A; Carson, D A et al. (1998) Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo. J Exp Med 187:433-8

Showing the most recent 10 out of 22 publications